
|Articles|September 16, 2015
European Survey Reveals Doctors' Prostate Cancer Concerns
September 16, 2015.
Advertisement
A pan-European survey has revealed that only 14% of healthcare professionals feel sufficiently equipped to address prostate cancer patients’ quality-of-life issues. Detailing the findings from a survey of 765 prostate cancer patients, 335 caregivers and 400 healthcare professionals across Europe, Prostate Cancer: Living, Not Just Surviving also states that for the patients who experience chronic physical effects from the disease, fatigue (66%) has the biggest negative impact compared to disability and pain (41% and 22% respectively), particularly in metastatic patients (93%) and patients on medication (83%). The report can be viewed online at
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Changing Reality of Pharmaceutical Commercialization in a Cold Chain-Driven Market
2
Vertex to Acquire Crinetics Pharmaceuticals for $10 Billion
3
Reshoring Pharma and Biotech Manufacturing Ahead of This Summer’s Tariff Deadlines: Q&A with Ryan Last
4
Catalent Announces Expanded Partnership with Nanoscope Therapeutics
5




